Publication: OncLive
Dr. Thomas E. Hutson of Texas Oncology−Charles A. Sammons Cancer spoke with OncLive about the efficacy of combination therapy to treat advanced renal cell carcinoma (RCC), specifically a 2-drug regimen approved by the FDA in May 2016.
Read the full story from OncLive.